IRADIMED CORPORATION (IRMD) FY2026 Q2 P&L / Income Statement

IRADIMED CORPORATION (IRMD) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue

20,466,000 US dollars

Cost of revenue

5,306,000 US dollars

Gross profit

15,160,000 US dollars

Total operating expenses

8,769,000 US dollars

Income from operations

6,391,000 US dollars

Other income, net

497,000 US dollars

Income before provision for income taxes

6,888,000 US dollars

Provision for income tax expense

1,670,000 US dollars

Net income

5,218,000 US dollars

MRI Compatible Intravenous ("IV") Infusion Pump Systems

6,428,000 US dollars

MRI Compatible Patient Vital Signs Monitoring Systems

6,665,000 US dollars

Ferro Magnetic Detection Systems

756,000 US dollars

Amortization of extended maintenance agreements

758,000 US dollars

Disposables

4,793,000 US dollars

Services and other

1,066,000 US dollars

General and administrative

3,866,000 US dollars

Sales and marketing

4,246,000 US dollars

Research and development

657,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.